nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—prostate cancer	0.356	1	CiPCiCtD
Gemcitabine—urinary bladder cancer—prostate cancer	0.25	1	CtDrD
Gemcitabine—TYMS—prostate cancer	0.0913	1	CbGaD
Gemcitabine—CDA—Capecitabine—prostate cancer	0.0683	0.393	CbGbCtD
Gemcitabine—TYMS—Capecitabine—prostate cancer	0.0304	0.175	CbGbCtD
Gemcitabine—ABCC10—Estradiol—prostate cancer	0.019	0.109	CbGbCtD
Gemcitabine—ABCC10—Etoposide—prostate cancer	0.0124	0.0714	CbGbCtD
Gemcitabine—ABCC10—Docetaxel—prostate cancer	0.0114	0.0653	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—prostate cancer	0.00846	0.0487	CbGbCtD
Gemcitabine—ABCB1—Estramustine—prostate cancer	0.00478	0.0275	CbGbCtD
Gemcitabine—ABCB1—Cabazitaxel—prostate cancer	0.00315	0.0181	CbGbCtD
Gemcitabine—ABCB1—Estrone—prostate cancer	0.00308	0.0177	CbGbCtD
Gemcitabine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00275	0.0158	CbGbCtD
Gemcitabine—ABCB1—Conjugated Estrogens—prostate cancer	0.00202	0.0116	CbGbCtD
Gemcitabine—ABCB1—Mitoxantrone—prostate cancer	0.00183	0.0105	CbGbCtD
Gemcitabine—ABCB1—Estradiol—prostate cancer	0.00177	0.0102	CbGbCtD
Gemcitabine—ABCB1—Prednisone—prostate cancer	0.00152	0.00876	CbGbCtD
Gemcitabine—ABCB1—Etoposide—prostate cancer	0.00116	0.00665	CbGbCtD
Gemcitabine—ABCB1—Docetaxel—prostate cancer	0.00106	0.00608	CbGbCtD
Gemcitabine—SLC28A1—renal system—prostate cancer	0.000952	0.0392	CbGeAlD
Gemcitabine—POLD1—prostate gland—prostate cancer	0.00093	0.0383	CbGeAlD
Gemcitabine—SLC28A3—prostate gland—prostate cancer	0.000853	0.0352	CbGeAlD
Gemcitabine—CDA—prostate gland—prostate cancer	0.000835	0.0344	CbGeAlD
Gemcitabine—ABCB1—Doxorubicin—prostate cancer	0.000788	0.00454	CbGbCtD
Gemcitabine—SLC29A2—prostate gland—prostate cancer	0.00078	0.0322	CbGeAlD
Gemcitabine—CMPK1—prostate gland—prostate cancer	0.000742	0.0306	CbGeAlD
Gemcitabine—POLE—prostate gland—prostate cancer	0.000695	0.0287	CbGeAlD
Gemcitabine—POLD1—renal system—prostate cancer	0.000634	0.0261	CbGeAlD
Gemcitabine—POLA1—prostate gland—prostate cancer	0.000599	0.0247	CbGeAlD
Gemcitabine—POLE—seminal vesicle—prostate cancer	0.000588	0.0242	CbGeAlD
Gemcitabine—RRM2—prostate gland—prostate cancer	0.000573	0.0236	CbGeAlD
Gemcitabine—POLA1—seminal vesicle—prostate cancer	0.000507	0.0209	CbGeAlD
Gemcitabine—CMPK1—renal system—prostate cancer	0.000506	0.0209	CbGeAlD
Gemcitabine—RRM1—prostate gland—prostate cancer	0.000476	0.0196	CbGeAlD
Gemcitabine—POLE—urethra—prostate cancer	0.000466	0.0192	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—prostate cancer	0.00044	0.0181	CbGeAlD
Gemcitabine—TYMS—prostate gland—prostate cancer	0.000431	0.0178	CbGeAlD
Gemcitabine—CDA—bone marrow—prostate cancer	0.00043	0.0177	CbGeAlD
Gemcitabine—POLD1—testis—prostate cancer	0.00041	0.0169	CbGeAlD
Gemcitabine—RRM1—seminal vesicle—prostate cancer	0.000402	0.0166	CbGeAlD
Gemcitabine—POLA1—urethra—prostate cancer	0.000401	0.0165	CbGeAlD
Gemcitabine—RRM2—renal system—prostate cancer	0.00039	0.0161	CbGeAlD
Gemcitabine—SLC29A1—prostate gland—prostate cancer	0.000387	0.0159	CbGeAlD
Gemcitabine—CMPK1—bone marrow—prostate cancer	0.000382	0.0158	CbGeAlD
Gemcitabine—Zalcitabine—CYP3A43—prostate cancer	0.000381	0.26	CrCbGaD
Gemcitabine—DCK—prostate gland—prostate cancer	0.00037	0.0152	CbGeAlD
Gemcitabine—CDA—testis—prostate cancer	0.000368	0.0152	CbGeAlD
Gemcitabine—POLE—bone marrow—prostate cancer	0.000358	0.0148	CbGeAlD
Gemcitabine—ABCC10—prostate gland—prostate cancer	0.000352	0.0145	CbGeAlD
Gemcitabine—CMPK1—testis—prostate cancer	0.000327	0.0135	CbGeAlD
Gemcitabine—RRM1—renal system—prostate cancer	0.000324	0.0134	CbGeAlD
Gemcitabine—RRM1—urethra—prostate cancer	0.000319	0.0131	CbGeAlD
Gemcitabine—DCK—seminal vesicle—prostate cancer	0.000313	0.0129	CbGeAlD
Gemcitabine—POLA1—bone marrow—prostate cancer	0.000309	0.0127	CbGeAlD
Gemcitabine—POLE—testis—prostate cancer	0.000306	0.0126	CbGeAlD
Gemcitabine—ABCC10—seminal vesicle—prostate cancer	0.000298	0.0123	CbGeAlD
Gemcitabine—POLD1—lymph node—prostate cancer	0.000297	0.0122	CbGeAlD
Gemcitabine—Azacitidine—DNMT1—prostate cancer	0.000297	0.203	CrCbGaD
Gemcitabine—RRM2—bone marrow—prostate cancer	0.000295	0.0122	CbGeAlD
Gemcitabine—Decitabine—DNMT1—prostate cancer	0.00029	0.198	CrCbGaD
Gemcitabine—CDA—lymph node—prostate cancer	0.000267	0.011	CbGeAlD
Gemcitabine—POLA1—testis—prostate cancer	0.000264	0.0109	CbGeAlD
Gemcitabine—SLC29A1—renal system—prostate cancer	0.000264	0.0109	CbGeAlD
Gemcitabine—SLC29A1—urethra—prostate cancer	0.000259	0.0107	CbGeAlD
Gemcitabine—RRM2—testis—prostate cancer	0.000252	0.0104	CbGeAlD
Gemcitabine—SLC29A2—lymph node—prostate cancer	0.000249	0.0103	CbGeAlD
Gemcitabine—DCK—urethra—prostate cancer	0.000247	0.0102	CbGeAlD
Gemcitabine—RRM1—bone marrow—prostate cancer	0.000245	0.0101	CbGeAlD
Gemcitabine—ABCC10—renal system—prostate cancer	0.00024	0.00989	CbGeAlD
Gemcitabine—CMPK1—lymph node—prostate cancer	0.000237	0.00977	CbGeAlD
Gemcitabine—ABCC10—urethra—prostate cancer	0.000236	0.00972	CbGeAlD
Gemcitabine—TYMS—bone marrow—prostate cancer	0.000222	0.00916	CbGeAlD
Gemcitabine—POLE—lymph node—prostate cancer	0.000222	0.00915	CbGeAlD
Gemcitabine—RRM1—testis—prostate cancer	0.00021	0.00864	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—prostate cancer	0.000199	0.00822	CbGeAlD
Gemcitabine—POLA1—lymph node—prostate cancer	0.000191	0.00789	CbGeAlD
Gemcitabine—DCK—bone marrow—prostate cancer	0.00019	0.00785	CbGeAlD
Gemcitabine—TYMS—testis—prostate cancer	0.00019	0.00783	CbGeAlD
Gemcitabine—RRM2—lymph node—prostate cancer	0.000183	0.00754	CbGeAlD
Gemcitabine—ABCC10—bone marrow—prostate cancer	0.000181	0.00748	CbGeAlD
Gemcitabine—POLE—Fulvestrant—Estradiol—prostate cancer	0.000177	0.132	CbGdCrCtD
Gemcitabine—SLC29A1—testis—prostate cancer	0.00017	0.00703	CbGeAlD
Gemcitabine—DCK—testis—prostate cancer	0.000163	0.00671	CbGeAlD
Gemcitabine—ABCC10—testis—prostate cancer	0.000155	0.00639	CbGeAlD
Gemcitabine—RRM1—lymph node—prostate cancer	0.000152	0.00626	CbGeAlD
Gemcitabine—TYMS—Docetaxel—Cabazitaxel—prostate cancer	0.000151	0.113	CbGdCrCtD
Gemcitabine—POLD1—Fulvestrant—Estradiol—prostate cancer	0.000148	0.111	CbGdCrCtD
Gemcitabine—Lamivudine—SLC22A3—prostate cancer	0.000148	0.101	CrCbGaD
Gemcitabine—TYMS—lymph node—prostate cancer	0.000138	0.00568	CbGeAlD
Gemcitabine—SLC29A1—lymph node—prostate cancer	0.000124	0.00509	CbGeAlD
Gemcitabine—DCK—lymph node—prostate cancer	0.000118	0.00486	CbGeAlD
Gemcitabine—RRM1—Fulvestrant—Estradiol—prostate cancer	0.000118	0.088	CbGdCrCtD
Gemcitabine—ABCC10—lymph node—prostate cancer	0.000112	0.00463	CbGeAlD
Gemcitabine—Lamivudine—SLC22A1—prostate cancer	0.000106	0.0723	CrCbGaD
Gemcitabine—TYMS—Paclitaxel—Cabazitaxel—prostate cancer	0.000104	0.078	CbGdCrCtD
Gemcitabine—ABCB1—prostate gland—prostate cancer	0.000102	0.00419	CbGeAlD
Gemcitabine—Zalcitabine—CYP3A5—prostate cancer	9.54e-05	0.0652	CrCbGaD
Gemcitabine—ABCB1—seminal vesicle—prostate cancer	8.6e-05	0.00354	CbGeAlD
Gemcitabine—Cytarabine—SLC22A1—prostate cancer	7.94e-05	0.0542	CrCbGaD
Gemcitabine—ABCB1—epithelium—prostate cancer	7.47e-05	0.00308	CbGeAlD
Gemcitabine—ABCB1—renal system—prostate cancer	6.93e-05	0.00286	CbGeAlD
Gemcitabine—ABCB1—urethra—prostate cancer	6.81e-05	0.00281	CbGeAlD
Gemcitabine—POLD1—Danazol—Ethinyl Estradiol—prostate cancer	6.48e-05	0.0485	CbGdCrCtD
Gemcitabine—ABCB1—bone marrow—prostate cancer	5.24e-05	0.00216	CbGeAlD
Gemcitabine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	5.19e-05	0.0388	CbGdCrCtD
Gemcitabine—ABCB1—testis—prostate cancer	4.48e-05	0.00185	CbGeAlD
Gemcitabine—TYMS—Paclitaxel—Docetaxel—prostate cancer	4.33e-05	0.0324	CbGdCrCtD
Gemcitabine—DCK—Fulvestrant—Estradiol—prostate cancer	4.19e-05	0.0314	CbGdCrCtD
Gemcitabine—Zalcitabine—CYP3A4—prostate cancer	4.13e-05	0.0282	CrCbGaD
Gemcitabine—POLA1—Norethindrone—Ethinyl Estradiol—prostate cancer	4e-05	0.0299	CbGdCrCtD
Gemcitabine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	3.93e-05	0.0294	CbGdCrCtD
Gemcitabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	3.84e-05	0.0287	CbGdCrCtD
Gemcitabine—DCK—Levorphanol—Estrone—prostate cancer	3.66e-05	0.0274	CbGdCrCtD
Gemcitabine—ABCB1—lymph node—prostate cancer	3.25e-05	0.00134	CbGeAlD
Gemcitabine—POLA1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	3.18e-05	0.0238	CbGdCrCtD
Gemcitabine—TYMS—Podofilox—Etoposide—prostate cancer	2.78e-05	0.0208	CbGdCrCtD
Gemcitabine—Cytarabine—CYP3A4—prostate cancer	2.77e-05	0.0189	CrCbGaD
Gemcitabine—DCK—Levorphanol—Estradiol—prostate cancer	2.77e-05	0.0207	CbGdCrCtD
Gemcitabine—TYMS—Levorphanol—Estrone—prostate cancer	2.75e-05	0.0206	CbGdCrCtD
Gemcitabine—POLD1—Danazol—Prednisone—prostate cancer	2.28e-05	0.017	CbGdCrCtD
Gemcitabine—TYMS—Levorphanol—Estradiol—prostate cancer	2.09e-05	0.0156	CbGdCrCtD
Gemcitabine—DCK—Doxorubicin—Epirubicin—prostate cancer	1.93e-05	0.0144	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—prostate cancer	1.78e-05	0.0133	CbGdCrCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—prostate cancer	1.4e-05	0.000223	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	1.4e-05	0.000222	CcSEcCtD
Gemcitabine—Cough—Capecitabine—prostate cancer	1.4e-05	0.000222	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—prostate cancer	1.39e-05	0.000221	CcSEcCtD
Gemcitabine—Pain—Etoposide—prostate cancer	1.39e-05	0.000221	CcSEcCtD
Gemcitabine—Constipation—Etoposide—prostate cancer	1.39e-05	0.000221	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—prostate cancer	1.38e-05	0.00022	CcSEcCtD
Gemcitabine—Hypertension—Capecitabine—prostate cancer	1.38e-05	0.00022	CcSEcCtD
Gemcitabine—TYMS—Danazol—Ethinyl Estradiol—prostate cancer	1.38e-05	0.0103	CbGdCrCtD
Gemcitabine—Sweating—Epirubicin—prostate cancer	1.37e-05	0.000218	CcSEcCtD
Gemcitabine—Arthralgia—Capecitabine—prostate cancer	1.36e-05	0.000217	CcSEcCtD
Gemcitabine—Myalgia—Capecitabine—prostate cancer	1.36e-05	0.000217	CcSEcCtD
Gemcitabine—Chest pain—Capecitabine—prostate cancer	1.36e-05	0.000217	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—prostate cancer	1.36e-05	0.000217	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.35e-05	0.000215	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—prostate cancer	1.35e-05	0.000215	CcSEcCtD
Gemcitabine—Anaphylactic shock—Docetaxel—prostate cancer	1.35e-05	0.000215	CcSEcCtD
Gemcitabine—Oedema—Docetaxel—prostate cancer	1.35e-05	0.000215	CcSEcCtD
Gemcitabine—Discomfort—Capecitabine—prostate cancer	1.35e-05	0.000214	CcSEcCtD
Gemcitabine—Infection—Docetaxel—prostate cancer	1.34e-05	0.000213	CcSEcCtD
Gemcitabine—Feeling abnormal—Etoposide—prostate cancer	1.34e-05	0.000213	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—prostate cancer	1.34e-05	0.000213	CcSEcCtD
Gemcitabine—Diarrhoea—Mitoxantrone—prostate cancer	1.34e-05	0.000213	CcSEcCtD
Gemcitabine—Vomiting—Estradiol—prostate cancer	1.33e-05	0.000212	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—prostate cancer	1.33e-05	0.000212	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—prostate cancer	1.33e-05	0.000211	CcSEcCtD
Gemcitabine—Nervous system disorder—Docetaxel—prostate cancer	1.32e-05	0.000211	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisone—prostate cancer	1.32e-05	0.000211	CcSEcCtD
Gemcitabine—Thrombocytopenia—Docetaxel—prostate cancer	1.32e-05	0.00021	CcSEcCtD
Gemcitabine—Rash—Estradiol—prostate cancer	1.32e-05	0.00021	CcSEcCtD
Gemcitabine—Dermatitis—Estradiol—prostate cancer	1.32e-05	0.00021	CcSEcCtD
Gemcitabine—Anaemia—Prednisone—prostate cancer	1.32e-05	0.00021	CcSEcCtD
Gemcitabine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	1.31e-05	0.00982	CbGdCrCtD
Gemcitabine—Headache—Estradiol—prostate cancer	1.31e-05	0.000209	CcSEcCtD
Gemcitabine—Skin disorder—Docetaxel—prostate cancer	1.31e-05	0.000209	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	1.31e-05	0.000208	CcSEcCtD
Gemcitabine—Oedema—Capecitabine—prostate cancer	1.31e-05	0.000208	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—prostate cancer	1.3e-05	0.000207	CcSEcCtD
Gemcitabine—Infection—Capecitabine—prostate cancer	1.3e-05	0.000207	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—prostate cancer	1.29e-05	0.000206	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—prostate cancer	1.29e-05	0.000205	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—prostate cancer	1.29e-05	0.000205	CcSEcCtD
Gemcitabine—Anorexia—Docetaxel—prostate cancer	1.29e-05	0.000205	CcSEcCtD
Gemcitabine—Malaise—Prednisone—prostate cancer	1.29e-05	0.000205	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—prostate cancer	1.28e-05	0.000204	CcSEcCtD
Gemcitabine—Body temperature increased—Etoposide—prostate cancer	1.28e-05	0.000204	CcSEcCtD
Gemcitabine—Nervous system disorder—Capecitabine—prostate cancer	1.28e-05	0.000204	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—prostate cancer	1.28e-05	0.000204	CcSEcCtD
Gemcitabine—Thrombocytopenia—Capecitabine—prostate cancer	1.28e-05	0.000204	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—prostate cancer	1.27e-05	0.000202	CcSEcCtD
Gemcitabine—Skin disorder—Capecitabine—prostate cancer	1.27e-05	0.000202	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—prostate cancer	1.27e-05	0.000201	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—prostate cancer	1.27e-05	0.000201	CcSEcCtD
Gemcitabine—Hyperhidrosis—Capecitabine—prostate cancer	1.26e-05	0.000201	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—prostate cancer	1.26e-05	0.000201	CcSEcCtD
Gemcitabine—Hypotension—Docetaxel—prostate cancer	1.26e-05	0.000201	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—prostate cancer	1.26e-05	0.0002	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—prostate cancer	1.26e-05	0.0002	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—prostate cancer	1.26e-05	0.0002	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—prostate cancer	1.25e-05	0.000199	CcSEcCtD
Gemcitabine—Anorexia—Capecitabine—prostate cancer	1.25e-05	0.000198	CcSEcCtD
Gemcitabine—Nausea—Estradiol—prostate cancer	1.24e-05	0.000198	CcSEcCtD
Gemcitabine—Vomiting—Mitoxantrone—prostate cancer	1.24e-05	0.000198	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—prostate cancer	1.23e-05	0.000196	CcSEcCtD
Gemcitabine—Hypertension—Prednisone—prostate cancer	1.23e-05	0.000196	CcSEcCtD
Gemcitabine—Rash—Mitoxantrone—prostate cancer	1.23e-05	0.000196	CcSEcCtD
Gemcitabine—Dermatitis—Mitoxantrone—prostate cancer	1.23e-05	0.000196	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.23e-05	0.000196	CcSEcCtD
Gemcitabine—Headache—Mitoxantrone—prostate cancer	1.22e-05	0.000195	CcSEcCtD
Gemcitabine—Hypotension—Capecitabine—prostate cancer	1.22e-05	0.000194	CcSEcCtD
Gemcitabine—Insomnia—Docetaxel—prostate cancer	1.22e-05	0.000194	CcSEcCtD
Gemcitabine—Myalgia—Prednisone—prostate cancer	1.21e-05	0.000193	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—prostate cancer	1.21e-05	0.000193	CcSEcCtD
Gemcitabine—Paraesthesia—Docetaxel—prostate cancer	1.21e-05	0.000193	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—prostate cancer	1.21e-05	0.000193	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.21e-05	0.000192	CcSEcCtD
Gemcitabine—Dyspnoea—Docetaxel—prostate cancer	1.2e-05	0.000191	CcSEcCtD
Gemcitabine—Somnolence—Docetaxel—prostate cancer	1.2e-05	0.000191	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—prostate cancer	1.2e-05	0.000191	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—prostate cancer	1.19e-05	0.00019	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.19e-05	0.000189	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—prostate cancer	1.19e-05	0.000189	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—prostate cancer	1.19e-05	0.000189	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—prostate cancer	1.19e-05	0.000189	CcSEcCtD
Gemcitabine—Insomnia—Capecitabine—prostate cancer	1.18e-05	0.000188	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—prostate cancer	1.18e-05	0.000187	CcSEcCtD
Gemcitabine—Paraesthesia—Capecitabine—prostate cancer	1.17e-05	0.000187	CcSEcCtD
Gemcitabine—Decreased appetite—Docetaxel—prostate cancer	1.17e-05	0.000187	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—prostate cancer	1.17e-05	0.000186	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—prostate cancer	1.17e-05	0.000186	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Docetaxel—prostate cancer	1.17e-05	0.000185	CcSEcCtD
Gemcitabine—Asthenia—Etoposide—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Dyspnoea—Capecitabine—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisone—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Oedema—Prednisone—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Fatigue—Docetaxel—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Nausea—Mitoxantrone—prostate cancer	1.16e-05	0.000185	CcSEcCtD
Gemcitabine—Immune system disorder—Epirubicin—prostate cancer	1.16e-05	0.000184	CcSEcCtD
Gemcitabine—Infection—Prednisone—prostate cancer	1.16e-05	0.000184	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—prostate cancer	1.15e-05	0.000184	CcSEcCtD
Gemcitabine—Pain—Docetaxel—prostate cancer	1.15e-05	0.000184	CcSEcCtD
Gemcitabine—Constipation—Docetaxel—prostate cancer	1.15e-05	0.000184	CcSEcCtD
Gemcitabine—Chills—Epirubicin—prostate cancer	1.15e-05	0.000183	CcSEcCtD
Gemcitabine—Pruritus—Etoposide—prostate cancer	1.15e-05	0.000183	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—prostate cancer	1.14e-05	0.000182	CcSEcCtD
Gemcitabine—Nervous system disorder—Prednisone—prostate cancer	1.14e-05	0.000182	CcSEcCtD
Gemcitabine—Decreased appetite—Capecitabine—prostate cancer	1.14e-05	0.000181	CcSEcCtD
Gemcitabine—Alopecia—Epirubicin—prostate cancer	1.13e-05	0.00018	CcSEcCtD
Gemcitabine—Skin disorder—Prednisone—prostate cancer	1.13e-05	0.00018	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Capecitabine—prostate cancer	1.13e-05	0.000179	CcSEcCtD
Gemcitabine—Fatigue—Capecitabine—prostate cancer	1.13e-05	0.000179	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—prostate cancer	1.13e-05	0.000179	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—prostate cancer	1.12e-05	0.000178	CcSEcCtD
Gemcitabine—Constipation—Capecitabine—prostate cancer	1.12e-05	0.000178	CcSEcCtD
Gemcitabine—Pain—Capecitabine—prostate cancer	1.12e-05	0.000178	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—prostate cancer	1.12e-05	0.000177	CcSEcCtD
Gemcitabine—Feeling abnormal—Docetaxel—prostate cancer	1.11e-05	0.000177	CcSEcCtD
Gemcitabine—Diarrhoea—Etoposide—prostate cancer	1.11e-05	0.000177	CcSEcCtD
Gemcitabine—Anorexia—Prednisone—prostate cancer	1.11e-05	0.000177	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—prostate cancer	1.1e-05	0.000175	CcSEcCtD
Gemcitabine—Back pain—Epirubicin—prostate cancer	1.08e-05	0.000172	CcSEcCtD
Gemcitabine—Feeling abnormal—Capecitabine—prostate cancer	1.08e-05	0.000171	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—prostate cancer	1.08e-05	0.000171	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—prostate cancer	1.07e-05	0.00017	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—prostate cancer	1.07e-05	0.00017	CcSEcCtD
Gemcitabine—Body temperature increased—Docetaxel—prostate cancer	1.07e-05	0.00017	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—prostate cancer	1.06e-05	0.000169	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.06e-05	0.000169	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—prostate cancer	1.06e-05	0.000169	CcSEcCtD
Gemcitabine—Insomnia—Prednisone—prostate cancer	1.05e-05	0.000168	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—prostate cancer	1.05e-05	0.000167	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—prostate cancer	1.04e-05	0.000166	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—prostate cancer	1.03e-05	0.000165	CcSEcCtD
Gemcitabine—Body temperature increased—Capecitabine—prostate cancer	1.03e-05	0.000164	CcSEcCtD
Gemcitabine—Vomiting—Etoposide—prostate cancer	1.03e-05	0.000164	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—prostate cancer	1.03e-05	0.000164	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—prostate cancer	1.03e-05	0.000164	CcSEcCtD
Gemcitabine—Rash—Etoposide—prostate cancer	1.02e-05	0.000163	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—prostate cancer	1.02e-05	0.000163	CcSEcCtD
Gemcitabine—Headache—Etoposide—prostate cancer	1.02e-05	0.000162	CcSEcCtD
Gemcitabine—Decreased appetite—Prednisone—prostate cancer	1.01e-05	0.000161	CcSEcCtD
Gemcitabine—Malaise—Epirubicin—prostate cancer	1.01e-05	0.00016	CcSEcCtD
Gemcitabine—Fatigue—Prednisone—prostate cancer	1e-05	0.00016	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—prostate cancer	9.98e-06	0.000159	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—prostate cancer	9.98e-06	0.000159	CcSEcCtD
Gemcitabine—Constipation—Prednisone—prostate cancer	9.95e-06	0.000158	CcSEcCtD
Gemcitabine—TYMS—Levonorgestrel—Ethinyl Estradiol—prostate cancer	9.88e-06	0.00739	CbGdCrCtD
Gemcitabine—Cough—Epirubicin—prostate cancer	9.73e-06	0.000155	CcSEcCtD
Gemcitabine—Asthenia—Docetaxel—prostate cancer	9.68e-06	0.000154	CcSEcCtD
Gemcitabine—Nausea—Etoposide—prostate cancer	9.64e-06	0.000153	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—prostate cancer	9.63e-06	0.000153	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisone—prostate cancer	9.59e-06	0.000153	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—prostate cancer	9.57e-06	0.000152	CcSEcCtD
Gemcitabine—Pruritus—Docetaxel—prostate cancer	9.55e-06	0.000152	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—prostate cancer	9.54e-06	0.000152	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—prostate cancer	9.49e-06	0.000151	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—prostate cancer	9.49e-06	0.000151	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—prostate cancer	9.49e-06	0.000151	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	9.43e-06	0.00015	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—prostate cancer	9.38e-06	0.000149	CcSEcCtD
Gemcitabine—Asthenia—Capecitabine—prostate cancer	9.37e-06	0.000149	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—prostate cancer	9.31e-06	0.000148	CcSEcCtD
Gemcitabine—Pruritus—Capecitabine—prostate cancer	9.24e-06	0.000147	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—prostate cancer	9.24e-06	0.000147	CcSEcCtD
Gemcitabine—Diarrhoea—Docetaxel—prostate cancer	9.23e-06	0.000147	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—prostate cancer	9.2e-06	0.000146	CcSEcCtD
Gemcitabine—Anaphylactic shock—Epirubicin—prostate cancer	9.1e-06	0.000145	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—prostate cancer	9.1e-06	0.000145	CcSEcCtD
Gemcitabine—Infection—Epirubicin—prostate cancer	9.04e-06	0.000144	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—prostate cancer	9e-06	0.000143	CcSEcCtD
Gemcitabine—Diarrhoea—Capecitabine—prostate cancer	8.94e-06	0.000142	CcSEcCtD
Gemcitabine—Nervous system disorder—Epirubicin—prostate cancer	8.93e-06	0.000142	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—prostate cancer	8.91e-06	0.000142	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—prostate cancer	8.91e-06	0.000142	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—prostate cancer	8.84e-06	0.000141	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—prostate cancer	8.8e-06	0.00014	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—prostate cancer	8.79e-06	0.00014	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—prostate cancer	8.79e-06	0.00014	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—prostate cancer	8.79e-06	0.00014	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.72e-06	0.000139	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—prostate cancer	8.68e-06	0.000138	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—prostate cancer	8.68e-06	0.000138	CcSEcCtD
Gemcitabine—Vomiting—Docetaxel—prostate cancer	8.58e-06	0.000137	CcSEcCtD
Gemcitabine—Rash—Docetaxel—prostate cancer	8.51e-06	0.000135	CcSEcCtD
Gemcitabine—Hypotension—Epirubicin—prostate cancer	8.5e-06	0.000135	CcSEcCtD
Gemcitabine—Dermatitis—Docetaxel—prostate cancer	8.5e-06	0.000135	CcSEcCtD
Gemcitabine—Headache—Docetaxel—prostate cancer	8.45e-06	0.000135	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—prostate cancer	8.42e-06	0.000134	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—prostate cancer	8.42e-06	0.000134	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—prostate cancer	8.37e-06	0.000133	CcSEcCtD
Gemcitabine—Asthenia—Prednisone—prostate cancer	8.35e-06	0.000133	CcSEcCtD
Gemcitabine—Vomiting—Capecitabine—prostate cancer	8.31e-06	0.000132	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.29e-06	0.000132	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—prostate cancer	8.26e-06	0.000131	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—prostate cancer	8.25e-06	0.000131	CcSEcCtD
Gemcitabine—Rash—Capecitabine—prostate cancer	8.24e-06	0.000131	CcSEcCtD
Gemcitabine—Pruritus—Prednisone—prostate cancer	8.23e-06	0.000131	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—prostate cancer	8.23e-06	0.000131	CcSEcCtD
Gemcitabine—Dermatitis—Capecitabine—prostate cancer	8.23e-06	0.000131	CcSEcCtD
Gemcitabine—Headache—Capecitabine—prostate cancer	8.18e-06	0.00013	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—prostate cancer	8.18e-06	0.00013	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—prostate cancer	8.17e-06	0.00013	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—prostate cancer	8.14e-06	0.00013	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—prostate cancer	8.11e-06	0.000129	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—prostate cancer	8.09e-06	0.000129	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—prostate cancer	8.03e-06	0.000128	CcSEcCtD
Gemcitabine—Nausea—Docetaxel—prostate cancer	8.02e-06	0.000128	CcSEcCtD
Gemcitabine—Diarrhoea—Prednisone—prostate cancer	7.96e-06	0.000127	CcSEcCtD
Gemcitabine—Decreased appetite—Epirubicin—prostate cancer	7.91e-06	0.000126	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisone—prostate cancer	7.89e-06	0.0059	CbGdCrCtD
Gemcitabine—Hypotension—Doxorubicin—prostate cancer	7.87e-06	0.000125	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—prostate cancer	7.86e-06	0.000125	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—prostate cancer	7.85e-06	0.000125	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—prostate cancer	7.78e-06	0.000124	CcSEcCtD
Gemcitabine—Pain—Epirubicin—prostate cancer	7.78e-06	0.000124	CcSEcCtD
Gemcitabine—Nausea—Capecitabine—prostate cancer	7.76e-06	0.000123	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.67e-06	0.000122	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisone—prostate cancer	7.65e-06	0.00572	CbGdCrCtD
Gemcitabine—Insomnia—Doxorubicin—prostate cancer	7.62e-06	0.000121	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—prostate cancer	7.56e-06	0.00012	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—prostate cancer	7.51e-06	0.000119	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—prostate cancer	7.5e-06	0.000119	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—prostate cancer	7.49e-06	0.000119	CcSEcCtD
Gemcitabine—Vomiting—Prednisone—prostate cancer	7.4e-06	0.000118	CcSEcCtD
Gemcitabine—Rash—Prednisone—prostate cancer	7.34e-06	0.000117	CcSEcCtD
Gemcitabine—Dermatitis—Prednisone—prostate cancer	7.33e-06	0.000117	CcSEcCtD
Gemcitabine—Decreased appetite—Doxorubicin—prostate cancer	7.32e-06	0.000117	CcSEcCtD
Gemcitabine—Headache—Prednisone—prostate cancer	7.29e-06	0.000116	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.27e-06	0.000116	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—prostate cancer	7.26e-06	0.000116	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—prostate cancer	7.2e-06	0.000115	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—prostate cancer	7.2e-06	0.000115	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—prostate cancer	7.2e-06	0.000114	CcSEcCtD
Gemcitabine—Feeling abnormal—Doxorubicin—prostate cancer	6.94e-06	0.00011	CcSEcCtD
Gemcitabine—Nausea—Prednisone—prostate cancer	6.91e-06	0.00011	CcSEcCtD
Gemcitabine—Body temperature increased—Doxorubicin—prostate cancer	6.66e-06	0.000106	CcSEcCtD
Gemcitabine—Asthenia—Epirubicin—prostate cancer	6.53e-06	0.000104	CcSEcCtD
Gemcitabine—Pruritus—Epirubicin—prostate cancer	6.44e-06	0.000102	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—prostate cancer	6.4e-06	0.00479	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—prostate cancer	6.32e-06	0.00472	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Prednisone—prostate cancer	6.25e-06	0.00468	CbGdCrCtD
Gemcitabine—Diarrhoea—Epirubicin—prostate cancer	6.23e-06	9.91e-05	CcSEcCtD
Gemcitabine—Asthenia—Doxorubicin—prostate cancer	6.04e-06	9.62e-05	CcSEcCtD
Gemcitabine—Pruritus—Doxorubicin—prostate cancer	5.96e-06	9.48e-05	CcSEcCtD
Gemcitabine—Vomiting—Epirubicin—prostate cancer	5.79e-06	9.21e-05	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisone—prostate cancer	5.76e-06	0.00431	CbGdCrCtD
Gemcitabine—Diarrhoea—Doxorubicin—prostate cancer	5.76e-06	9.17e-05	CcSEcCtD
Gemcitabine—Rash—Epirubicin—prostate cancer	5.74e-06	9.13e-05	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—prostate cancer	5.73e-06	9.12e-05	CcSEcCtD
Gemcitabine—Headache—Epirubicin—prostate cancer	5.7e-06	9.07e-05	CcSEcCtD
Gemcitabine—Nausea—Epirubicin—prostate cancer	5.41e-06	8.6e-05	CcSEcCtD
Gemcitabine—Vomiting—Doxorubicin—prostate cancer	5.35e-06	8.52e-05	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—prostate cancer	5.31e-06	8.45e-05	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—prostate cancer	5.31e-06	8.44e-05	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—prostate cancer	5.28e-06	8.4e-05	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisone—prostate cancer	5.05e-06	0.00378	CbGdCrCtD
Gemcitabine—Nausea—Doxorubicin—prostate cancer	5e-06	7.96e-05	CcSEcCtD
Gemcitabine—TYMS—Danazol—Prednisone—prostate cancer	4.84e-06	0.00362	CbGdCrCtD
Gemcitabine—CMPK1—Metabolism—PIK3CA—prostate cancer	2.9e-06	7.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—prostate cancer	2.89e-06	7.28e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MDM2—prostate cancer	2.87e-06	7.23e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1A1—prostate cancer	2.85e-06	7.18e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC5A5—prostate cancer	2.85e-06	7.18e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—prostate cancer	2.85e-06	7.17e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ERCC2—prostate cancer	2.83e-06	7.13e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—prostate cancer	2.83e-06	7.12e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—prostate cancer	2.83e-06	7.12e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—prostate cancer	2.8e-06	7.05e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARA—prostate cancer	2.79e-06	7.03e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2E1—prostate cancer	2.79e-06	7.01e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARA—prostate cancer	2.78e-06	6.99e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	2.78e-06	6.99e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NQO1—prostate cancer	2.76e-06	6.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	2.75e-06	6.93e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—INS—prostate cancer	2.75e-06	6.92e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—prostate cancer	2.74e-06	6.89e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TH—prostate cancer	2.72e-06	6.83e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—prostate cancer	2.71e-06	6.82e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CKMT2—prostate cancer	2.7e-06	6.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UGT2B17—prostate cancer	2.7e-06	6.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GRHPR—prostate cancer	2.7e-06	6.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UGT2B15—prostate cancer	2.7e-06	6.8e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CREBBP—prostate cancer	2.69e-06	6.78e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—prostate cancer	2.69e-06	6.77e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP3A4—prostate cancer	2.69e-06	6.76e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	2.69e-06	6.76e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—prostate cancer	2.66e-06	6.7e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1B1—prostate cancer	2.64e-06	6.65e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CAV1—prostate cancer	2.63e-06	6.61e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—prostate cancer	2.62e-06	6.61e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—prostate cancer	2.61e-06	6.58e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAV1—prostate cancer	2.61e-06	6.57e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARA—prostate cancer	2.61e-06	6.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	2.6e-06	6.55e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—prostate cancer	2.58e-06	6.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	2.58e-06	6.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	2.57e-06	6.47e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GGT1—prostate cancer	2.56e-06	6.44e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CD—prostate cancer	2.55e-06	6.43e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAGLU—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AOX1—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SULT2B1—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RFK—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM3—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MBTPS1—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PGAM2—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—prostate cancer	2.54e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—prostate cancer	2.53e-06	6.36e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NCOA1—prostate cancer	2.52e-06	6.34e-05	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—prostate cancer	2.52e-06	6.33e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—prostate cancer	2.5e-06	6.3e-05	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—prostate cancer	2.5e-06	6.3e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP19A1—prostate cancer	2.48e-06	6.25e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAV1—prostate cancer	2.46e-06	6.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	2.45e-06	6.17e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—prostate cancer	2.42e-06	6.1e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—prostate cancer	2.42e-06	6.09e-05	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—prostate cancer	2.42e-06	6.08e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—prostate cancer	2.41e-06	6.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	2.41e-06	6.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AMACR—prostate cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP3A43—prostate cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT1—prostate cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SRD5A2—prostate cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DEGS1—prostate cancer	2.41e-06	6.06e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—prostate cancer	2.41e-06	6.05e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RXRA—prostate cancer	2.4e-06	6.03e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—prostate cancer	2.39e-06	6.02e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	2.38e-06	6e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—prostate cancer	2.38e-06	5.99e-05	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—prostate cancer	2.37e-06	5.96e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—prostate cancer	2.34e-06	5.9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	2.32e-06	5.85e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—COMT—prostate cancer	2.31e-06	5.81e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—prostate cancer	2.3e-06	5.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	2.3e-06	5.79e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—prostate cancer	2.3e-06	5.78e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD17B1—prostate cancer	2.3e-06	5.78e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—INS—prostate cancer	2.27e-06	5.7e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ITPR1—prostate cancer	2.26e-06	5.69e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—INS—prostate cancer	2.25e-06	5.67e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—prostate cancer	2.25e-06	5.65e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—prostate cancer	2.24e-06	5.63e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CB—prostate cancer	2.23e-06	5.6e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CREBBP—prostate cancer	2.22e-06	5.58e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—prostate cancer	2.21e-06	5.55e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CREBBP—prostate cancer	2.21e-06	5.55e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	2.19e-06	5.51e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—INS—prostate cancer	2.12e-06	5.33e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—prostate cancer	2.11e-06	5.31e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CD—prostate cancer	2.1e-06	5.29e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—prostate cancer	2.1e-06	5.28e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CD—prostate cancer	2.09e-06	5.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.09e-06	5.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	2.08e-06	5.23e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CREBBP—prostate cancer	2.07e-06	5.22e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—LPL—prostate cancer	2.07e-06	5.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	2.05e-06	5.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—B4GALT4—prostate cancer	2.05e-06	5.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HPGD—prostate cancer	2.05e-06	5.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	2.02e-06	5.08e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—prostate cancer	2.01e-06	5.05e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A1—prostate cancer	2e-06	5.04e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—prostate cancer	1.99e-06	5e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ERCC2—prostate cancer	1.99e-06	5e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.98e-06	4.97e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—prostate cancer	1.97e-06	4.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.97e-06	4.96e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CD—prostate cancer	1.97e-06	4.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.92e-06	4.84e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—prostate cancer	1.92e-06	4.84e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.88e-06	4.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTAP—prostate cancer	1.87e-06	4.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP7B1—prostate cancer	1.87e-06	4.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.87e-06	4.71e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—prostate cancer	1.87e-06	4.7e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—prostate cancer	1.86e-06	4.67e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—prostate cancer	1.83e-06	4.62e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.83e-06	4.61e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CB—prostate cancer	1.83e-06	4.61e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARA—prostate cancer	1.83e-06	4.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SULT1E1—prostate cancer	1.82e-06	4.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SRD5A1—prostate cancer	1.82e-06	4.59e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CB—prostate cancer	1.82e-06	4.59e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—prostate cancer	1.82e-06	4.57e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—prostate cancer	1.81e-06	4.54e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—prostate cancer	1.79e-06	4.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.78e-06	4.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.77e-06	4.45e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACSL4—prostate cancer	1.74e-06	4.38e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD17B3—prostate cancer	1.74e-06	4.38e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.73e-06	4.35e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.72e-06	4.34e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—prostate cancer	1.72e-06	4.33e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAV1—prostate cancer	1.72e-06	4.33e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CB—prostate cancer	1.71e-06	4.31e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—prostate cancer	1.7e-06	4.27e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UMPS—prostate cancer	1.67e-06	4.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ARG2—prostate cancer	1.67e-06	4.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PHGDH—prostate cancer	1.67e-06	4.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.66e-06	4.18e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—prostate cancer	1.65e-06	4.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.64e-06	4.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LDHB—prostate cancer	1.64e-06	4.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP3A5—prostate cancer	1.61e-06	4.04e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.6e-06	4.02e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—prostate cancer	1.58e-06	3.99e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.58e-06	3.97e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—prostate cancer	1.57e-06	3.96e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—prostate cancer	1.57e-06	3.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.56e-06	3.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PDHA1—prostate cancer	1.55e-06	3.9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UCP3—prostate cancer	1.55e-06	3.9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA3—prostate cancer	1.55e-06	3.9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TCN2—prostate cancer	1.55e-06	3.9e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—prostate cancer	1.51e-06	3.8e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—prostate cancer	1.5e-06	3.78e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—INS—prostate cancer	1.48e-06	3.74e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—prostate cancer	1.48e-06	3.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD3B1—prostate cancer	1.48e-06	3.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC22A3—prostate cancer	1.48e-06	3.73e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—prostate cancer	1.46e-06	3.68e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CREBBP—prostate cancer	1.45e-06	3.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.43e-06	3.6e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.43e-06	3.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA4—prostate cancer	1.42e-06	3.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TBXAS1—prostate cancer	1.42e-06	3.57e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—prostate cancer	1.41e-06	3.55e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.4e-06	3.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA2—prostate cancer	1.38e-06	3.48e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CD—prostate cancer	1.38e-06	3.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCG5—prostate cancer	1.37e-06	3.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SULT1A1—prostate cancer	1.37e-06	3.44e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—prostate cancer	1.36e-06	3.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA1—prostate cancer	1.33e-06	3.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.32e-06	3.33e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD3B2—prostate cancer	1.32e-06	3.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTO1—prostate cancer	1.32e-06	3.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT2—prostate cancer	1.32e-06	3.32e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—prostate cancer	1.3e-06	3.28e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLCB2—prostate cancer	1.26e-06	3.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LRP2—prostate cancer	1.26e-06	3.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2C18—prostate cancer	1.26e-06	3.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—P4HB—prostate cancer	1.24e-06	3.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.22e-06	3.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC22A1—prostate cancer	1.21e-06	3.04e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.21e-06	3.04e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CB—prostate cancer	1.2e-06	3.02e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—prostate cancer	1.19e-06	3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SULT2A1—prostate cancer	1.18e-06	2.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.18e-06	2.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MED12—prostate cancer	1.16e-06	2.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNG5—prostate cancer	1.15e-06	2.89e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—prostate cancer	1.12e-06	2.81e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—prostate cancer	1.11e-06	2.8e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—prostate cancer	1.11e-06	2.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NCOA3—prostate cancer	1.11e-06	2.78e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HPGDS—prostate cancer	1.05e-06	2.65e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2C19—prostate cancer	1.05e-06	2.64e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—prostate cancer	1.04e-06	2.63e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—prostate cancer	1.04e-06	2.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—prostate cancer	1.02e-06	2.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACHE—prostate cancer	1.02e-06	2.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2A6—prostate cancer	1.01e-06	2.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.93e-07	2.5e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—prostate cancer	9.9e-07	2.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKR1C3—prostate cancer	9.84e-07	2.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PRKACB—prostate cancer	9.78e-07	2.46e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP17A1—prostate cancer	9.68e-07	2.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.58e-07	2.41e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NCOA2—prostate cancer	9.23e-07	2.32e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—prostate cancer	9.13e-07	2.3e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—prostate cancer	9.08e-07	2.28e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A5—prostate cancer	8.8e-07	2.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2E1—prostate cancer	8.6e-07	2.16e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—prostate cancer	8.53e-07	2.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NQO1—prostate cancer	8.5e-07	2.14e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TH—prostate cancer	8.38e-07	2.11e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP3A4—prostate cancer	8.29e-07	2.09e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1B1—prostate cancer	8.15e-07	2.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GGT1—prostate cancer	7.89e-07	1.99e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NCOA1—prostate cancer	7.78e-07	1.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP19A1—prostate cancer	7.66e-07	1.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RXRA—prostate cancer	7.4e-07	1.86e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—prostate cancer	7.32e-07	1.84e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—COMT—prostate cancer	7.12e-07	1.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—prostate cancer	7.09e-07	1.78e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ITPR1—prostate cancer	6.98e-07	1.76e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMS—prostate cancer	6.59e-07	1.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—prostate cancer	6.52e-07	1.64e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LPL—prostate cancer	6.4e-07	1.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A1—prostate cancer	6.18e-07	1.55e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ERCC2—prostate cancer	6.13e-07	1.54e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—prostate cancer	5.98e-07	1.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—prostate cancer	5.76e-07	1.45e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARA—prostate cancer	5.65e-07	1.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAV1—prostate cancer	5.31e-07	1.34e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—prostate cancer	4.84e-07	1.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—INS—prostate cancer	4.58e-07	1.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CREBBP—prostate cancer	4.49e-07	1.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CD—prostate cancer	4.25e-07	1.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—prostate cancer	4.02e-07	1.01e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CB—prostate cancer	3.71e-07	9.33e-06	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—prostate cancer	3.67e-07	9.24e-06	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—prostate cancer	3.2e-07	8.06e-06	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—prostate cancer	3.06e-07	7.69e-06	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—prostate cancer	2.26e-07	5.69e-06	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—prostate cancer	1.85e-07	4.65e-06	CbGpPWpGaD
